US bank JPMorgan has raised its target price for Symrise from 115 to 120 euros ahead of the publication of quarterly figures at the end of April and left its rating at Overweight. The flavor.
Analyst Edward Hockin from JP Morgan research considers the stock attractive and recommends it with a Buy rating. The target price remains unchanged at EUR 115.